Market Overview - As of June 15, 2025, there are 267 companies listed on the Beijing Stock Exchange (BSE), with a total share capital of 37.331 billion shares and a circulating share capital of 23.848 billion shares [2] - For the week of June 9 to June 15, the BSE recorded a trading volume of 7.448 billion shares, a week-on-week increase of 63.81%, and a trading value of 1630.50 billion yuan, up 64.09% from the previous week [3] Index Performance - The BSE 50 Index fell by 3.11% to 1382.74 points during the same week, with 10 stocks rising, none remaining flat, and 35 stocks declining [3] - The top performer was Air China Ocean (833171), which increased by 24.44%, while the largest decline was seen in Binhang Technology (839493), which dropped by 12.60% [3] New Listings and Applications - One company successfully listed on the BSE during the week, bringing the total to 267 [6] - There are currently 83 companies awaiting approval, with 15 under review, 57 in inquiry, and 10 submitted for registration [5] Company Highlights - **Jiaoda Iron Development Co., Ltd. (920027)**: Listed on May 13, 2025, with a first-day trading surge of 295.91%, closing at 31.90 yuan, a 262.09% increase. The company focuses on intelligent products and equipment for rail transit [8][9] - **Sanxie Electric Co., Ltd. (873669)**: Passed the listing committee meeting on June 9, 2025, aiming to raise 1.59 billion yuan for expansion and R&D projects [12][13] - **New Hengtai New Materials Co., Ltd. (874327)**: Received listing application acceptance on June 10, 2025, with plans to raise 3.80 billion yuan for new material projects [15][16] - **Koleidi Medical Equipment Co., Ltd. (873414)**: Listed application accepted on June 12, 2025, seeking to raise 2.99 billion yuan for product development and production [17][18] - **Ying's Holdings Group Co., Ltd. (874431)**: Received listing application acceptance on June 13, 2025, with plans to raise 3.34 billion yuan for various projects [19][20] Financial Performance - **Jiaoda Iron Development**: Reported revenues of 2.35 billion yuan, 2.73 billion yuan, and 3.35 billion yuan from 2022 to 2024, with net profits of 337.99 million yuan, 476.56 million yuan, and 533.92 million yuan respectively [9] - **Sanxie Electric**: Expected to achieve revenue of 2.35 billion to 2.48 billion yuan in the first half of 2025, with a net profit forecast of 28.80 million to 30.50 million yuan [13] - **New Hengtai**: Achieved revenues of 5.30 billion yuan, 6.79 billion yuan, and 7.74 billion yuan from 2022 to 2024, with net profits of 450.00 million yuan, 1.01 billion yuan, and 917.64 million yuan respectively [16] - **Koleidi Medical**: Reported revenues of 2.33 billion yuan, 2.38 billion yuan, and 2.85 billion yuan from 2022 to 2024, with net profits of 693.67 million yuan, 599.18 million yuan, and 672.15 million yuan respectively [18] - **Ying's Holdings**: Reported revenues of 12.96 billion yuan, 17.58 billion yuan, and 19.74 billion yuan from 2022 to 2024, with net profits of 1.17 billion yuan, 2.20 billion yuan, and 2.11 billion yuan respectively [20][21]

Government Initiatives - The National Intellectual Property Administration is focusing on promoting collaborative innovation in Heilongjiang, Jilin, Liaoning, and Inner Mongolia to leverage the region's rich scientific and educational resources [2][4] - Heilongjiang has established an integrated service platform for intellectual property, enhancing service delivery across the province [4] - Jilin is developing pilot zones for intellectual property protection to support technological innovation and new productivity [4] - Liaoning is improving its intellectual property policy framework and strengthening protection systems to support private enterprise development [4] - Inner Mongolia has created a comprehensive system for patent navigation and high-value patent cultivation [4] Corporate Innovations - Companies across various sectors in Northeast China are actively creating, utilizing, and protecting intellectual property, with notable achievements in industries such as food, healthcare, steel, and robotics [5] - Benxi Steel has institutionalized its intellectual property management, holding 832 effective patents, including 73 high-value patents, and aims to be recognized as a national model enterprise by 2024 [5] - Shenyang Deshi Cold Drink Co., Ltd. has registered over 900 trademarks and 600 design patents, making it a leader in intellectual property within the cold drink industry [5] - Heilongjiang Flying Crane Dairy has integrated patent technology with industry standards, establishing the largest domestic breast milk database with 659 authorized patents [6] - Harbin Sizerui Intelligent Medical Equipment Co., Ltd. has applied for over 500 patents, with nearly 300 authorized, and its surgical robot has been used in over 6,000 surgeries [6] Academic Contributions - Harbin Engineering University is developing a systematic approach to patent revitalization and technology transfer, focusing on high-value patent cultivation [11] - The Chinese Academy of Sciences' Shenyang Institute of Automation has achieved significant technology transfer, generating approximately 80 million RMB through patent licensing [14] - The Heilongjiang Academy of Agricultural Sciences has established a modern agricultural intellectual property operation center, completing 8 patent transfers worth 12 million RMB [14]

一个最新例证是罗氏诊断在华投资的新项目。5月13日，罗氏诊断新投资项目在苏州工业园区正式奠 基。项目总规划用地108亩，是罗氏诊断在华最大的单笔投资项目。 为招引世界500强罗氏集团新项目，苏州工业园区成立重点项目工作专班，多次召开协调会，成功推动 建立牛血清白蛋白和人血清进口及长效管理等机制，让罗氏集团最终决定将子公司罗氏诊断的亚太试剂 及仪器设备生产和研发基地新投资项目落地园区。"苏州工业园区投资促进委员会相关负责人坦言，"项 目累计投资将达10亿瑞士法郎，预计2028年正式投产。 苏州工业园区公布的数据显示，截至目前，苏州工业园区累计吸引外资项目超5200个，累计实际利用外 资超420亿美元，108家世界500强企业在区内投资了189个项目，是江苏省首个"外资总部经济集聚区"。 在苏州工业园区，空调通风领域"隐形冠军"妥思集团的亚太研发制造总部项目已进入全面建设阶段，包 括土建施工、设备采购及智能化工厂规划。这是妥思集团在海外最大的单笔投资项目，预计总投资7000 万美元，计划于2026年建成投产。 这既是苏州工业园区对外资"磁吸力"增强的一个生动注脚，也是苏州工业园区外贸外资"第一梯队"地位 进一步巩 ...

Group 1 - The private economy is a vital force in promoting Chinese-style modernization and is an important foundation for achieving high-quality development [1] - Private enterprises account for over 92% of the total number of enterprises in China, with more than 420,000 private high-tech enterprises, also exceeding 92% [1] - Focusing on core business and strengthening the real economy is an inherent requirement for high-quality development in the private sector [1] Group 2 - Ningxia Wuzhong Instrument Co., Ltd. has specialized in control valves for over 60 years, which are crucial for the safety, quality, and efficient operation of process industrial systems [2] - After initially losing direction post-IPO, the company refocused on control valves, leading to significant growth and becoming a "little giant" in the specialized and innovative sector [2] - The 2024 China Private Enterprises Top 500 report shows that manufacturing enterprises account for 66.4% of the list, indicating a continuous increase over three years [2] Group 3 - Guangzhou Mingluo Equipment Co., Ltd. has successfully developed its own assembly system for automotive manufacturing, previously dominated by foreign companies [3][4] - The company has updated its assembly system to the third generation and has entered markets in the US, Germany, and Japan [4] - Other companies like Shenzhen Keman Medical Equipment Co., Ltd. and Ningxia Xinjing New Materials Technology Co., Ltd. are also innovating in their respective fields, contributing to high-quality development [4] Group 4 - Dalian First Current Transformer Co., Ltd. is a leading player in the current transformer industry, focusing on talent development and innovation [5] - The company has achieved significant cost reductions in supply chain management and manufacturing through integrated data sharing [5] - The government is enhancing services to support private enterprises, exemplified by the streamlined processes for business registration and tax matters [6] Group 5 - The implementation of the Private Economy Promotion Law provides legal support for private enterprises to focus on their core business and strengthen the real economy [6] - The Ministry of Industry and Information Technology is committed to improving the business environment and supporting enterprises in their pursuit of high-quality development [6][7]

证券研究报告：医药生物|行业周报 发布时间：2025-06-16 行业投资评级 强于大市 |维持 行业基本情况 | 收盘点位 | | 7895.79 | | --- | --- | --- | | 52 | 周最高 | 8490.25 | | 52 周最低 | | 6070.89 | 行业相对指数表现 2024-06 2024-08 2024-11 2025-01 2025-04 2025-06 -14% -11% -8% -5% -2% 1% 4% 7% 10% 13% 16% 19% 医药生物 沪深300 资料来源：聚源，中邮证券研究所 研究所 分析师:蔡明子 SAC 登记编号:S1340523110001 Email:caimingzi@cnpsec.com 分析师:龙永茂 SAC 登记编号:S1340523110002 Email:longyongmao@cnpsec.com 近期研究报告 推荐标的：英科医疗、迈普医学、怡和嘉业、微电生理、 拱东医疗、派林生物、益丰药房、大参林、康臣药业、佐力药 业、桂林三金、天士力、新里程、美年健康、国际医学。 《政策支持上市公司通过并购重组高 质量发展，行业整合持 ...

2025 年 06 月 16 日 王睿哲 C0062@capital.com.tw 目标价(元) 155 股价相对大盘走势 C o m p a n y U p d a t e 公司基本资讯 | 产业别 | | | 医药生物 | | --- | --- | --- | --- | | A 股价(2025/6/13) | | | 129.50 | | 上证指数(2025/6/13) | | | 3377.00 | | 股价 12 个月高/低 | | | 151.86/91.91 | | 总发行股数(百万) | | | 824.16 | | A 股数(百万) | | | 593.30 | | A 市值(亿元) | | | 768.32 | | 主要股东 | | | 联影医疗技术集 | | | | | 团有限公司 | | | | | (20.33%) | | 每股净值(元) | | | 24.61 | | 股价/账面净值 | | | 5.26 | | 一个月 | | 三个月 | 一年 | | 股价涨跌(%) | -5.9 | 0.3 | 12.1 | 近期评等 | 日期 | 收盘价 | 评级 | | --- | -- ...

Core Viewpoint - The report highlights Yirui Technology as a leading domestic digital X-ray detector manufacturer, emphasizing its comprehensive product matrix and significant market share in the global landscape [2][5]. Product and Market Position - Yirui Technology has developed over 100 types of digital X-ray detectors, covering various medical and industrial applications, with a shipment increase from 67,000 units in 2021 to 105,500 units in 2023, representing a compound annual growth rate (CAGR) of over 25% [2]. - The company accounted for 20.09% of the global digital X-ray detector shipments in 2023, with a total global shipment forecast of 525,300 units [2]. Business Expansion and Growth Potential - The company is expanding into the core components and overall solutions market, with projected revenue from core components reaching 126 million yuan in 2024, a year-on-year growth of approximately 45.5% [3]. - The overall solutions segment is expected to generate around 96 million yuan in 2024, reflecting a staggering year-on-year growth of 262.56% [3]. - The company has initiated projects for medical DR, C-arm, and CT products, with an anticipated production value of nearly 5 billion yuan by 2030 [3]. Core Component Market Opportunity - The global tube market is projected to grow from $4.26 billion in 2023 to $9.53 billion by 2030, with a CAGR of 12.18% [4]. - Yirui Technology has begun developing various types of tubes since 2022, with some products nearing mass production and achieving international advanced standards [4]. Financial Projections - Revenue forecasts for Yirui Technology are expected to reach 2.266 billion yuan, 3.100 billion yuan, and 4.133 billion yuan for 2025, 2026, and 2027, respectively, with year-on-year growth rates of 23.7%, 36.8%, and 33.3% [5]. - Net profit projections for the same years are 597 million yuan, 790 million yuan, and 1.044 billion yuan, with growth rates of 28.3%, 32.3%, and 32.2% [5].

Group 1 - The fourth China-Africa Economic and Trade Expo is taking place in Changsha, showcasing a variety of African products alongside Chinese goods, emphasizing cooperation opportunities under the theme "China-Africa Together to Dream of Modernization" [1] - The exhibition covers an area of 100,000 square meters with over 4,700 domestic and foreign enterprises displaying products across categories such as agricultural products, engineering machinery, electronic products, and handicrafts [1] - In the first five months of this year, China's total trade with Africa reached 963.21 billion yuan, marking a year-on-year increase of 12.4%, setting a historical record for the same period [2] Group 2 - Agricultural cooperation is expanding, with more high-quality African agricultural products entering the Chinese market; during the expo, China Customs signed five agreements for the import of agricultural products from four African countries [3] - A total of 38 entities from China and Africa signed 28 contracts worth $5.27 billion during the infrastructure cooperation exchange event, covering various sectors including transportation, logistics, energy, and housing construction [4] - The expo serves as a platform for promoting high-tech Chinese products such as new energy vehicles and solar panels, which are gaining popularity in Africa, indicating new directions for China-Africa economic cooperation [5] Group 3 - The expo features a "African Good Products" themed live broadcast, promoting African products through cross-border e-commerce platforms, and a service fund of 1 billion yuan was announced to foster China-Africa cross-border industrial chains [6] - Entrepreneurs from Africa are eager to establish online sales channels for their products, highlighting the growing interest in e-commerce and digital platforms for trade between China and Africa [6] - The expo is seen as a strong force for high-quality development in China-Africa economic cooperation, bringing new opportunities and platforms for collaboration [6]

截至2025年6月13日收盘，三星医疗（601567）报收于22.34元，较上周的22.38元下跌0.18%。本周，三 星医疗6月10日盘中最高价报23.23元。6月11日盘中最低价报21.94元。三星医疗当前最新总市值315.22 亿元，在电网设备板块市值排名8/120，在两市A股市值排名454/5150。 三星医疗召开第六届董事会第二十三次会议，审议通过了关于变更部分回购股份用途为注销并减少公司 注册资本的议案。公司将存放于股份回购专用证券账户中已回购尚未使用的5,755,371股股份用途由"用 于实施员工持股计划或股权激励计划"变更为"用于注销并减少公司注册资本"。注销完成后，公司总股 本预计将由1,411,006,571股变更为1,405,251,200股，注册资本预计将由1,411,006,571元变更为 1,405,251,200元。公司通知各债权人，自接到公司通知起30日内、未接到通知者自本公告披露之日起45 日内，有权凭有效债权文件及相关凭证要求公司清偿债务或者提供相应担保。债权申报时间为2025年6 月14日至2025年7月28日，每日8:30-12:00；13:30-18:00（双休日及法 ...

中金点睛"本周精选"栏目将带您回顾本周深受读者欢迎的研究报告。 01 房地产 Industry 2025下半年展望 | 房地产：信心、耐心与决心 >>点击图片查看全文<< 我们认为房地产市场"止跌回稳"是一个循序渐进的过程，可大体分为三个阶段，分别对应"住房交易量"、"房价"、"房地产投资"三类指标的企稳回 升；其中，步入正循环的核心点是供需结构改变带来的房价预期向上，或应成为市场耐心跟踪关注的关键转折信号。政策端促成"止跌回稳"仍需更大 决心，推进实体市场供需结构调整的措施落地和防范化解企业端衍生风险的措施补充是短期关键。我们此前在2025年度策略《 房地产：迈向止跌回 稳 》中提出三种政策强度情景；考虑到年初以来政策进展和市场表现、房地产政策约束条件的突破仍须时间、市场供需结构较历史上景气周期仍有 差距，我们认为对于房地产基本面磨底期的持续时长做充分估计，2025年演绎"中政策"情景的概率较大，其中仅销量表现由于926政策效果持续时长 超预期或略好于"中政策"情景。而一旦供需结构调整带动价格预期转为积极，我们认为总住房销量修复至历史合理水平对应的上行空间十分可观， 一、二手房占比结构的再平衡也意味着新房交 ...